Irina Apostolou
Corporate Officer/Principal chez CONSTELLATION PHARMACEUTICALS, INC.
Profil
She is an immunologist by training and an accomplished drug discovery and translational research leader with over 13 years of cross-functional leadership roles in large pharma and biotech in the therapeutic areas of Immuno-Oncology, Autoimmunity, Inflammation and Oncology.
Irina has a deep experience in developing and executing strategies for target mining, selection, validation, and at advancing drug programs from discovery to in vitro and in vivo proof-of concept, PK/PD, and safety pharmacology studies.
Throughout her professional experience in the pharmaceutical industry, she has acquired an extensive experience working with and forging successful, long-term relationships with academic investigators, and is well-versed in conducting scientific and technical due diligence and assessment for partnering, investing, and licensing opportunities.
As part of the OTD Alliance Corporate Team, Irina serves as the primary scientific liaison between Harvard OTD and the Alliance partner to spearhead the identification of projects.
She works closely with Harvard faculty and their research teams to develop project proposals that bridge the gap between basic research and the drug development process, and manages project execution in collaboration with Harvard faculty.
Irina earned her B.Sc.
in Molecular Biology & Genetics, M.Sc.
in Cellular & Molecular Genetics, and Ph.D.
in Genetics & Immunology from the Paris-Sud University in France.
She was also a Research Fellow and an Instructor in Pathology at Harvard Medical School.
Postes actifs de Irina Apostolou
Sociétés | Poste | Début |
---|---|---|
CONSTELLATION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2016 |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - |
Anciens postes connus de Irina Apostolou
Sociétés | Poste | Fin |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 31/07/2016 |
Formation de Irina Apostolou
Institut Universitaire de Technologie de Cachan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PFIZER, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |